Vascular Medicine Fellowship

Thank you for your interest in the Vascular Medicine Fellowship at Michigan Medicine. This one-year, non-invasive fellowship prepares fellows to sit for the American Board of Vascular Medicine examination. While the board certification is designed for internal medicine physicians (both general internal medicine and specialists), we welcome applications from any physician with a strong interest in the care of patients with vascular disorders.

With a strong focus on vascular laboratory study interpretation, fellows will also be prepared to sit for the Registered Physician in Vascular Interpretation (RPVI) Certification examination at the end of their training.

Applications can be submitted by email to Kaitlin Spencer by November 30, 2021. Please include the following in your application:

• Current CV
• Letter of interest or personal statement
• Two (2) letters of recommendation
• One (1) letter of recommendation from your most recent program director, assistant program director, or direct supervisor (if not currently in residency/fellowship)

Interviews will be conducted by Zoom. If you have questions during the application process, please do not hesitate to contact us:

Kaitlin Spencer, Program Coordinator
734-998-7500 (phone)

The one-year fellowship program consists of both inpatient and outpatient training across a broad set of disciplines. In addition to the rotations, fellows will participate in a continuity clinic with one or more of the vascular medicine faculty. All clinical work is conducted at Michigan Medicine, the academic medical center at the University of Michigan.

Vascular Medicine (VM)

• VM Continuity Clinic (outpatient)
• Multidisciplinary Venous Clinic and PAD Clinic, Lymphedema Treatment (outpatient)
• Pulmonary Embolism Response Team (PERT) Consults (inpatient)

Vascular Lab

• Perform and Interpret Vascular Studies (outpatient)

Cardiology

• Aortic Diseases Clinic (outpatient)
• Hypertension Clinic and Hyperlipidemia Clinic (outpatient)
• Pulmonary Hypertension/Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Clinic (outpatient)
• Cardiology Consults (inpatient)

Endocrine

• Podiatry Clinic (outpatient)
• Diabetes Clinic (outpatient)

Hematology

• Thrombophilia Clinic (outpatient)
• Benign Hematology Consults (inpatient)

Interventional Radiology (IR)

• IR Procedures (inpatient)

Neurology

• Stroke Clinic (outpatient)
• Stroke Consults and Service (inpatient)

Radiology

• Vascular Imaging Interpretation (outpatient)

Rheumatology

• Vasculitis, Antiphospholipid Syndrome, and Lupus Clinics (outpatient)

Vascular Surgery

• Vascular Surgery Outpatient Clinic (outpatient)
• Vascular Surgery Inpatient Service (inpatient)

Additional

• Anticoagulation Clinic
• Smoking Cessation

All vascular medicine trainees will be provided with four weeks of dedicated research time and will be connected with an appropriate research mentor early in their training program. They will be expected to submit at least one abstract to an annual meeting (e.g., Anticoagulation Forum, THSNA, Society of Vascular Medicine).

Health Services Research

Dr. Geoffrey Barnes and Dr. James Froehlich lead or participate in several programs that are home to large registries and datasets, and have mentored countless trainees on a variety of research projects supported by a large team of research coordinators and statistical analysts.

• Dr. Barnes and Dr. Froehlich are directors of the Michigan Anticoagulation Quality Improvement Initiative (MAQI2), a multi-center quality collaborative focused on anticoagulation care, with a registry of over 15,000 patients on oral anticoagulants.
• Dr. Barnes is a core faculty member at the Institute for Healthcare Policy & Innovation, where he has access to many large datasets (including Medicare, OptumInsight, and Marketscan).
• Dr. Froehlich is the director of the Michigan Clinical Outcomes Research & Reporting Program, where the International Registry of Aortic Dissection and many other outcomes registries are managed.

Basic and Translational Research

Trainees will have access to the considerable breadth and depth of expertise of all vascular biology and thrombosis investigators at Michigan Medicine.

• The Frankel Cardiovascular Center houses one of the premier basic and translational thrombosis research programs in the country, with expertise in coagulation, platelet biology, thrombo-inflammation, and chronic pulmonary thromboembolic disease.
• Drs. Kanthi, Ganesh, and Hofmann Bowman run highly productive basic and translational research labs with a strong track record for mentoring trainees. Their vascular research labs in the Cardiovascular Research Institute are adjacent to one another for added synergies and collaboration.
  • Kanthi Lab - Translational research lab that has a footprint on both the National Institutes of Health campus and the University of Michigan. His research team studies molecules at the intersection of inflammation and thrombosis with a focus on deep vein thrombosis and pulmonary embolism. Trainees will have access to unique potential opportunities for experience in translational investigation of vascular disease.
  • Ganesh Lab - Focuses on hypertension and genetic arteriopathies, including fibromuscular dysplasia. Dr. Ganesh also leads the Michigan Biological Research Initiative on Sex Differences in Cardiovascular Disease (M-BRISC) program.
  • Hofmann Bowman Lab - Focuses on aortopathies, including aortic dissection and aneurysm. Dr. Hofmann Bowman is also the director of the Aortic Disease program. 

The Frankel Cardiovascular Center also has multiple T32 training programs for interested trainees who would benefit from two additional years of research training for career development. Dr. Barnes and Dr. Kanthi are both former T32 trainees from this program. Training is available for either health services research or basic and/or translational research. Trainee experiences are structured, with a mentorship committee and formal coursework in research methodologies. 

• Geoffrey Barnes, MD, MSc, FSVM (Fellowship Director) - Dr. Barnes is board certified in vascular medicine, cardiovascular medicine, and internal medicine as well as RPVI certified. He is a national and international expert in venous thromboembolism and anticoagulation. His outpatient practice focuses on a wide range of vascular medicine disorders with an emphasis on anticoagulation and venous thromboembolism, and also serves as director of the Pulmonary Embolism Response Team. Dr. Barnes is also a health services researcher who co-directs the Michigan Anticoagulation Quality Improvement Initiative (MAQI2) and leads NIH and AHRQ-funded research efforts that improve and evaluate the delivery of anticoagulation therapy.
• Yogen Kanthi, MD, FSVM (Fellowship Co-Director) - Dr. Kanthi is board certified in cardiovascular medicine, internal medicine, board eligible in vascular medicine, and RPVI certified. He also serves as a member on the Society for Vascular Medicine Board of Trustees. Dr. Kanthi is a national and international expert in thrombosis, and runs a highly productive basic and translational research laboratory at the NIH studying inflammation and thrombosis.
• James Froehlich, MD, MPH, FSVM (Director of Vascular Medicine) - Dr. Froehlich is a national and international expert in anticoagulation, aortopathies, fibromuscular dysplasia, and perioperative care. He serves as co-director for the Michigan Medicine Diagnostic Vascular Unit (vascular lab) and is a past president of the Society for Vascular Medicine. Dr. Froehlich's clinical practice encompasses a wide range of vascular and cardiovascular conditions. He is also the director of the Michigan Cardiovascular Outcomes Research and Reporting Program.
• Vikas Aggarwal, MBBS, MPH - Dr. Aggarwal is a board-certified vascular medicine and cardiovascular medicine specialist who has clinical expertise in acute and chronic management of venous thromboembolism, chronic thromboembolic pulmonary hypertension, peripheral artery disease, and interventional cardiology.
• Santhi Ganesh, MD - Dr. Ganesh is a cardiovascular medicine clinician who is a national and international expert in genetic vascular disorders and fibromuscular dysplasia. She runs a highly productive basic and translational science lab focused on vasculopathy, including fibromuscular dysplasia and spontaneous coronary artery dissection. Dr. Ganesh has current and/or recent funding from the NIH and other prestigious foundations.
• Henry Han, MD - Dr. Han is a current cardiovascular medicine fellow and recent graduate of the vascular medicine fellowship program (2020-2021). He is actively involved in health services research projects focused on safe delivery of anticoagulation care under the mentorship of Dr. Barnes.
• Marion Hofmann Bowman, MD - Dr. Hofmann Bowman is a cardiovascular specialist who has clinical and research expertise in aortic and genetic vascular pathology, and is the medical director of the Aortic Diseases program at the Frankel Cardiovascular Center.
• Sayed (Nabeel) Hyder, MD - Dr. Hyder is a board-eligible internal medicine physician who is currently completing his vascular medicine fellowship at Michigan Medicine. His research focuses on the care of patients with acute and chronic pulmonary vascular disease under the mentorship of Dr. Aggarwal and Dr. Barnes.
• Melvyn Rubenfire, MD - Dr. Rubenfire is a board certified cardiovascular specialist who has a clinical focus on the management of preventive cardiology and hyperlipidemia.

Kaitlin Spencer, Program Coordinator 
Michigan Medicine
2800 Plymouth Rd
NCRC Building 25, 2L 01N
Ann Arbor, MI 48109-2800
734-998-7500 (phone)
734-998-7711 (fax)